Quest Diagnostics Incorporated (BMV:DGX)

Mexico flag Mexico · Delayed Price · Currency is MXN
3,395.60
+24.65 (0.73%)
At close: May 13, 2025
38.14%
Market Cap 371.56B
Revenue (ttm) 207.62B
Net Income (ttm) 18.23B
Shares Out n/a
EPS (ttm) 161.63
PE Ratio 20.38
Forward PE 17.13
Dividend 60.24 (1.77%)
Ex-Dividend Date Apr 7, 2025
Volume 15
Average Volume 2,730
Open 3,395.60
Previous Close 3,370.95
Day's Range 3,395.60 - 3,395.60
52-Week Range 2,844.15 - 3,395.60
Beta n/a
RSI 62.70
Earnings Date Jul 22, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]

Industry Medical Laboratories
Founded 1967
Employees 56,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol DGX
Full Company Profile

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD Financial Statements

News

There is no news available yet.